Pharmacology

Action Mechanism of Action Reference
INHIBITOR DNA inhibitor DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Gallbladder Neoplasms 3 D005706 ClinicalTrials
Klatskin Tumor 3 D018285 ClinicalTrials
Central Nervous System Neoplasms 3 D016543 ClinicalTrials
Bile Duct Neoplasms 3 D001650 ClinicalTrials
Head and Neck Neoplasms 2 D006258 ClinicalTrials
Esophageal Neoplasms 2 D004938 ClinicalTrials
Mesothelioma 2 D008654 ClinicalTrials
Lung Neoplasms 2 D008175 ClinicalTrials
Brain Neoplasms 2 D001932 ClinicalTrials
Mesothelioma 2 D008654 ClinicalTrials
Head and Neck Neoplasms 2 D006258 ClinicalTrials
Urinary Bladder Neoplasms 1 D001749 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 1 D002289 ClinicalTrials
Small Cell Lung Carcinoma 0 D055752 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL1201481
FDA SRS Y3834SIK5F